tirzepatide and glaucoma Semaglutide or Optic Nerve and Visual Pathway Disorders in Type 2 Diabetes Tirzepatide Associated with Lower POAG,

Appetite is lowered: Semaglutide acts on areas in the brain involved in appetite and satiety, which can reduce hunger

Clinicians should monitor thyroid function tests (TSH, free T4) at: Baseline before starting weight loss injections 6-8 weeks after achieving maintenance dose Every 3-6 months during active weight loss After significant weight stabilization Symptoms of overreplacement (palpitations, anxiety, tremor, heat intolerance) should prompt earlier testing

39-year-old male: On semaglutide for 2 weeks, lost 7 pounds

In a late-stage study, the drug helped people with diabetes and who were overweight or obese lose up to 15.7% of their body weight about 34 pounds over the course of roughly 17 months, the company said

Parks, 60, of Bend, Ore